María Ángeles
Serrano García
Hospital Universitario de Salamanca
Salamanca, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Salamanca (9)
2012
-
No correlation between the expression of FXR and genes involved in multidrug resistance phenotype of primary liver tumors
Molecular Pharmaceutics, Vol. 9, Núm. 6, pp. 1693-1704
-
Up-regulation of FXR isoforms is not required for stimulation of the expression of genes involved in the lack of response of colon cancer to chemotherapy
Pharmacological Research, Vol. 66, Núm. 5, pp. 419-427
2011
-
A homozygous nonsense mutation (c.214C→A) in the biliverdin reductase alpha gene (BLVRA) results in accumulation of biliverdin during episodes of cholestasis
Journal of Medical Genetics, Vol. 48, Núm. 4, pp. 219-225
2008
-
Molecular bases of the fetal liver - Placenta - Maternal liver excretory pathway for cholephilic compounds
Liver International, Vol. 28, Núm. 4, pp. 435-454
-
Role of vitamin C transporters and biliverdin reductase in the dual pro-oxidant and anti-oxidant effect of biliary compounds on the placental-fetal unit in cholestasis during pregnancy
Toxicology and Applied Pharmacology, Vol. 232, Núm. 2, pp. 327-336
2007
2006
-
Excretion of fetal biliverdin by the rat placenta-maternal liver tandem
American Journal of Physiology - Regulatory Integrative and Comparative Physiology, Vol. 290, Núm. 3
2005
-
Long-term effect of treating pregnant rats with ursodeoxycholic acid on the congenital impairment of bile secretion induced in the pups by maternal cholestasis
Journal of Pharmacology and Experimental Therapeutics, Vol. 312, Núm. 2, pp. 751-758
1983
-
Serum glycosidases in diabetes mellitus in relation to the retinopathy and to the length of the disease
Clinica Chimica Acta, Vol. 132, Núm. 1, pp. 23-27